`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`TARO PHARMACEUTICALS U.S.A., INC.,
`
`Petitioner,
`
`v.
`
`APOTEX TECHNOLOGIES INC.,
`
`Patent Owner
`
`
`Case IPR2017-01446
`U.S. Patent No. 7,049,328
`
`Title: USE OF DEFERIPRONE
`
`
`NOTICE OF STIPULATION - MODIFICATION OF DUE DATE 2
`
`
`
`
`
`
`
`NOTICE OF STIPULATION OF DUE DATE 2
`
`Apotex Technologies, Inc. (“Patent Owner”) and Petitioner Taro
`
`Pharmaceuticals U.S.A., Inc., (“Petitioner”) by and through their respective
`
`counsel, have stipulated as follows:
`
`1.
`
`
`
`On November 28, 2017, the Patent Trial and Appeal Board issued a
`
`Scheduling Order (Paper No. 8) in the Inter Partes Review of U.S. Patent No.
`
`7,049,328 (Case No. IPR2017-01446) setting forth the dates “for the parties to take
`
`action after institution of the proceeding.” Scheduling Order (Paper No. 8) at 2.
`
`2.
`
`
`
`The Scheduling Order further states that “[t]he parties may stipulate
`
`different dates for DUE DATES 1 through 5 (earlier or later, but no later than DUE
`
`DATE 6).” Id.
`
`3.
`
`
`
`The parties previously stipulated (Paper No. 13) to modify DUE
`
`DATES 1 and 2 as follows (without prejudice to requesting further changes to the
`
`schedule):
`
`DUE DATE 1
`
`DUE DATE 2
`
`Patent owner’s response to the
`petition/Patent owner’s motion to
`amend the patent
`Petitioner’s reply to patent owner’s
`response to petition/Petitioner’s
`opposition to motion to amend
`
`February 22, 2018
`
`May 10, 2018
`
`
`Notice Of Stipulation – Modification Of Due Dates 1 And 2 (Paper No. 13) at 2.
`
`4.
`
`
`
`The parties have now stipulated to further modify DUE DATE 2 as
`
`follows (without prejudice to requesting further changes to the schedule):
`
`
`
`2
`
`
`
`DUE DATE 2
`
`Petitioner’s reply to patent owner’s
`response to petition/Petitioner’s
`opposition to motion to amend
`
`June 13, 2018
`
`
`
`5.
`
`
`
`Because Patent Owner did not move under 37 C.F.R. § 42.121 to
`
`amend the patent, the due dates for Petitioner’s opposition to motion to amend and
`
`Patent Owner’s reply to Petitioner’s opposition to motion to amend are moot.
`
`6.
`
`
`
`The stipulation does not affect or otherwise modify DUE DATE 3
`
`through DUE DATE 7 in the Scheduling Order.
`
`
`
`Dated: April 18, 2018
`
`
`
`
`
`
`
`Respectfully submitted,
`By: /W. Blake Coblentz/
`W. Blake Coblentz (Reg. No. 57,104)
`Cozen O’Connor
`1200 19th Street, N.W.
`Washington, DC 20036
`Tel: (202) 912-4800
`Counsel for Patent Owner
`
`By: /Huiya Wu/
`Huiya Wu (Reg. No. 44,411)
`Robert V. Cerwinski (to seek pro hac vice
`admission)
`Sarah Fink (Reg. No. 64,886)
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`Tel: (212) 813-8800
`Counsel for Petitioner
`
`3
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on April 18, 2018, I caused to be served a copy of this
`
`NOTICE OF STIPULATION - MODIFICATION OF DUE DATE 2 via electronic
`
`mail on the following counsel of record:
`
`
`
`W. Blake Coblentz
`Aaron S. Lukas
`Barry Golob
`
`Email:
`wcoblentz@cozen.com
`alukas@cozen.com
`bgolob@cozen.com
`
`
`
`
`
`
`
`/Sarah Fink/
`Sarah Fink
`
`4
`
`